AIM Honor Ningbo Biopharmaceutical

AIM Honor Ningbo Biopharmaceutical, a key subsidiary of AIM Vaccine Co., Ltd., is a China-based biopharmaceutical company specializing in the research, development, and manufacturing of human vaccines. The company is best known for its large-scale production of human rabies vaccines (Vero cell), holding a significant share of the Chinese market. Beyond its commercial portfolio, AIM Honor is actively advancing a pipeline of next-generation vaccines, including mRNA-based candidates for COVID-19 and other infectious diseases. The company operates high-standard GMP manufacturing facilities in Ningbo and serves as a critical pillar in AIM Vaccine's integrated vaccine value chain.